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Abstract
In animals with heteromorphic sex chromosomes, all sex differences originate from the sex chromosomes, which
are the only factors that are consistently different in male and female zygotes. In mammals, the imbalance in Y
gene expression, specifically the presence vs. absence of Sry, initiates the differentiation of testes in males, setting
up lifelong sex differences in the level of gonadal hormones, which in turn cause many sex differences in the
phenotype of non-gonadal tissues. The inherent imbalance in the expression of X and Y genes, or in the epigenetic
impact of X and Y chromosomes, also has the potential to contribute directly to the sexual differentiation of
non-gonadal cells. Here, we review the research strategies to identify the X and Y genes or chromosomal regions
that cause direct, sexually differentiating effects on non-gonadal cells. Some mouse models are useful for separating
the effects of sex chromosomes from those of gonadal hormones. Once direct “sex chromosome effects” are
detected in these models, further studies are required to narrow down the list of candidate X and/or Y genes and
then to identify the sexually differentiating genes themselves. Logical approaches to the search for these genes are
reviewed here.
Keywords: Sex determination, Sexual differentiation, Sex chromosomes, X chromosome, Y chromosome,
Testosterone, Estradiol, Gonadal hormones
Background
In animals with an unmatched (heteromorphic) pair of
sex chromosomes, all sex differences in the phenotype
originate from the unequal effects of the sex chromo-
somes because they are the only factors that consistently
differ between male and female zygotes. In species such
as mammals in which the sex chromosomes are XX and
XY, a fundamental goal is to identify the sex-biasing
effects of the two sex chromosomes on phenotypes. This
review discusses the strategies for identifying X and Y
genes or mechanisms that cause sexual bias, using
mouse models that differ in their sex chromosome
complement, including differences in the parental source
of the X chromosome.
Primary among the sexually unbalanced effects of X and
Y genes are those that cause sexual differentiation of the
gonads. In mammals, the most important sex differences
in the gonads are thought to be initiated by the Y-linked
gene Sry, which is expressed in the indifferent gonadal
ridge of males and induces there a cascade of molecular
and cellular events that commit that tissue to a testicular
fate [1–4]. In the absence of Sry in the XX female, ovaries
develop through an active developmental program that
includes inhibition of testicular pathways [5]. Therefore,
the developmentally limited male-specific expression of
Sry in the gonads sets up a lifelong sex difference in
secretion of testicular vs. ovarian hormones. Because sex
steroid hormones, especially androgens and estrogens, are
considered the major class of proximate signals that act
throughout the body to cause sexual differentiation, the
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Sry effect has long been thought to be primarily res-
ponsible for determining the sexual phenotype of most
mammalian species.
In addition to the effects of Sry on gonadal tissues, X
and Y genes may be expressed at different levels in XX
and XY non-gonadal cells as a consequence of their
imbalance in the genomes of all XX and XY cells. By
virtue of this imbalance, X and Y genes are known to
cause numerous sex differences in phenotype [6–11].
These X and Y gene effects are here called “direct”
effects of the sex chromosomes, because the sex bias in
the X and Y gene expressions acts directly to cause sex
differences in non-gonadal tissues instead of indirectly
via an action on the gonads to induce sex differences
caused by gonadal hormones [12]. Historically, it has
been much easier to study the effects of gonadal
hormones, which can be administered or blocked or
withdrawn by simple experimental procedures. It has
been much more difficult to discover the direct sex-
biased effects of the X and Y genes on non-gonadal
tissues, because altering the sex chromosome comple-
ment usually causes changes in the type or function of
the gonads, and therefore introduces confounding differ-
ences in the level of gonadal secretions.
Here, we review mouse models (see also [13]) that
enable the separation of sex chromosome complement
effects from the hormonal confounds, thus facilitating
the identification of direct sex chromosome effects (dir-
ect SCEs) that contribute to sex differences. We focus
especially on direct SCEs that are expected to contribute
to sex differences in the function of normal XX and XY
cells. The goal of our studies, and of this review, is not
only to discuss how to detect direct SCEs but also to
map out a strategy for identifying the X or Y genes that
cause sex differences in cells. The strategy represents a
logic tree, which progressively narrows down the poten-
tial candidate genes responsible for direct SCEs.
Anatomy of the mouse sex chromosomes and
possible causes of sex differences in phenotype
The mammalian sex chromosomes are thought to have
evolved from an ancestral pair of autosomes. One auto-
some, the proto-Y chromosome, acquired a dominant
male-determining locus, which led to the loss of
recombination with the proto-X, and ultimately, to the
wholesale loss of gene-encoding DNA from the Y
chromosome [14, 15]. However, there have been gene
additions to the X and/or Y chromosome subsequent to
their divergence [16–20]. The present-day Y chromo-
some is usually small and gene-poor relative to the X
chromosome [21, 22]. However, the mouse Y has an
unusually high gene count as a result of massive gene
amplification that is thought to be driven by an ongoing
post-meiotic X-Y genomic conflict [22, 23]. During
meiosis, the X and Y chromosomes pair at the pseu-
doautosomal regions (PARs), thus enabling the X and Y
PARs to recombine [24–27]. The X and Y PARs are
therefore identical on average between males and
females and are not thought to cause sex differences in
phenotypes. The number and type of sex chromosomes
present in females or males are referred to as the sex
chromosome complement, and we use this term to
encompass the parental imprinting and inactivation
status of the X chromosomes (see below). For the
purposes of this review, we break down the sex chromo-
some complement into a number of components that
could contribute to sex differences in phenotypes. Aside
from the PARs, which are present in two doses in female
and male mice, the genomic dosage of these components
is not the same in males and females (Table 1 and Fig. 1).
Thus, females have two copies of the non-PAR region of
the X chromosome (NPX), whereas males have one
NPX and one non-PAR Y (NPY). Females also differ
from males in that they receive an X chromosome from
each parent, whereas males only receive an X from their
mother. Because of parental imprinting, gene expression
can differ between the maternal and paternal X chromo-
somes. Also, as is discussed more fully below, one of the
X chromosomes in females is “inactivated.” Thus, about
half of female cells inactivate the maternal X chromo-
some and experience the paternal X imprint (unlike any
male cell), whereas the other half of the cells inactivate
the paternal X chromosome and experience the maternal
X imprint (similar to male cells). The inherent imbal-
ance in the sex chromosome complement that results in
a difference in gene expression between XX and XY cells
can therefore be summarized as follows: (1) the absence
vs. the presence of the NPY genes, (2) the difference in
genomic dose of NPX genes (two vs. one copies), (3) any
differences due to the parental imprint on the NPX
genes, and (4) the presence vs. the absence of an inactive
X chromosome (Table 1).
Without any compensatory mechanism, the double
genomic representation of X genes in XX cells, com-
pared to the single representation of those genes in XY
cells, would create an imbalance in X gene expression
Table 1 XX vs. XY genomic dose for sex chromosome
complement components
Genotypes Gonads NPX NPY [−Sry] Sry PAR [−Sts] Sts Xm Xp Xi
XX (40,XX) F 2 0 0 2 2 1 1 1
XY (40,XY) M 1 1 1 2 2 1 0 0
Sry and Sts are separated from the chromosomal regions that encompass
them because mouse variants with sex chromosomes deleted for one or both
of these genes are utilized in crosses
NPX non-PAR X genes, NPY non-PAR Y genes (excluding Sry), PAR pseudoauto-
somal region (excluding Sts), Xp X chromosome of paternal origin, Xm X
chromosome of maternal origin, Xi the inactive X which may be of maternal or
paternal origin
Burgoyne and Arnold Biology of Sex Differences  (2016) 7:68 Page 2 of 21
between the sexes (F>M); such a chromosome-wide
sexual imbalance in expression is thought to be disad-
vantageous because X genes would not be in balance in
both sexes with autosomal genes that they drive or that
drive them [28]. X-inactivation, the process by which
one X chromosome is largely transcriptionally silenced
in non-germline XX cells, is an effective mechanism that
reduces the imbalance in X gene expression. However,
X-inactivation does not eliminate sex differences in the
expression of X genes but reduces it to match approxi-
mately the level of sexual dimorphism in the expression
of genes encoded on autosomes, which are present in
two copies in each sex [29]. It also introduces the possi-
bility of epigenetic effects of the inactive X, which are
discussed more fully below.
X inactivation leads to mosaicism of X gene expression
in XX mice. In eutherian mammals such as the mouse,
the choice to inactivate the paternal or maternal X
chromosome is random and patchy in tissues stemming
from the inner cell mass of the blastocyst (i.e., the tissues
giving rise to the body of the embryo), so that some som-
atic XX cells predominantly express X genes inherited
from the mother, and others express X genes inherited
from the father [30]. In outbred or natural populations
that carry genetic polymorphisms, there are two types of
X mosaicism—of the alleles and imprints. Because the
maternally derived X chromosome will have many alleles
that are different from those on the paternally derived X
chromosome, roughly half of the cells in the XX mice will
express the paternal X alleles and show the effects of any
paternal imprint on X genes, and the other half will
express the maternal X alleles and evince the effects of
any maternal imprint on X genes. Thus, females are
expected to have fewer extreme tissue phenotypes,
because the extreme effects of specific X alleles (e.g.,
causing abnormal function) is often buffered by the expres-
sion of another allele in other cells of the same individual
[31–33]. These effects are thought to lead to sex differences
in the variability of tissue phenotypes (XX females less
variable than XY males), and broader adaptiveness of
female tissues to diverse environments because of the in-
herently greater diversity of X alleles within an individual
female vs. an individual male. However, an overall reduced
variability of X gene expression in human females, relative
to males, has not been supported [34] but might be import-
ant under extreme environmental conditions or disease.
Thus, we can expand the list of possible sources of sex
differences in phenotype arising from differences in sex
chromosome complement, to include the following: (5)
The inherent mosaicism of XX tissues arising from
random X inactivation, which can lead to less phe-
notypic variability among females than males and to
average differences in phenotype between the sexes; (6)
sex differences in the prevalence of specific X alleles that
may also lead to average phenotypic differences between
the sexes. However, when studying inbred mice, all X
alleles are the same in the two sexes, so these additional
sources of sex differences are not operative.
Fig. 1 Major parts of the mouse X and Y chromosomes. Top: The
170-Mb X chromosome is divided into the pseudoautosomal region
(PAR), containing the Sts gene and a few others, and the non-PAR
region (NPX). The 89-Mb Y chromosome comprises the PAR and
non-PAR Y (NPY). The Sry gene is on the Y chromosome short arm.
Bottom: XX progeny inherit X chromosomes from the mother (Xm)
and father (Xp). The XX mouse is a mosaic of cells expressing one of
the parental X chromosomes. Green shows the patches of tissues in
which Xp is active, and lavender shows the patches in which Xm is
active. The XY mouse inherits the Xm and expresses only that X
chromosome in all tissues. CEN centromere
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Finally, it is possible that the difference in sex chromo-
some complement between normal males and females
can lead to direct SCEs that are linked to the epigenetic
status of the sex chromosomes rather than differences in
X and Y gene expression [35–38]. One example of this
arises from the fact that in somatic cells, the inactive X
(Xi) in females is rich in heterochromatin, reflecting the
limited transcriptional activity. Heterochromatinization
depends on enzymes that introduce repressive marks on
histones, and it is hypothesized that heterochromatiniza-
tion of the X competes with the introduction of repres-
sive marks at some autosomal loci, thus affecting
autosomal gene expression in females. This could be
linked to a direct SCE even though it is not linked to an
XX vs. XY difference in X gene expression. We do not
consider this type of epigenetic contribution to direct
SCEs further.
Two mouse models that identify direct SCEs
An ideal mouse model for identifying direct SCEs is one
that provides mice that differ in their sex chromosome
complement (XX vs. XY) but not in the level of gonadal
secretions. In practice, this is an elusive goal, but some
experimental paradigms are informative even if strict
control of gonadal hormone levels may not always be
possible.
Sf1 KO mice
One approach to eliminating the hormonal confound is
to study mice that lack gonads. The most useful gonad-
less mice to date are those lacking steroidogenic factor 1
(Sf1, also known as Nr5a1 and Ad4bp). Sf1-null mice of
both sexes are born without gonads or adrenals and have
a malformed hypothalamus [39, 40]. They die at birth
because of the lack of glucocorticoids but are kept alive
by injections of corticosterone and transplantation of
adrenals [41, 42]. Such gonadless mice show XX vs. XY
differences in some neural phenotypes, indicating that
some sex differences, seen in gonadally intact mice in
the same litters, are caused by direct non-gonadal effects
arising from the difference in sex chromosome comple-
ment [43]. This model is valuable because it compares
XX and XY mice or tissues that have never been ex-
posed to gonadal secretions. However, the model has
two main disadvantages: the homozygous Sf1-null mice
are produced from heterozygous null parents, so that
each litter produces a relatively small number of homo-
zygous null pups, and each homozygous mouse must
receive an adrenal transplant. We do not consider this
model further.
“Four core genotypes” (FCG) mice
The FCG model [44], in which the Sry gene causing
testis development has been “moved” from the Y
chromosome to an autosome, is so far the model most
often used for separating the effects of sex chromosome
complement from the effects of gonadal type. In general,
the model can be used to identify sex differences caused
by gonadal hormones (testicular vs. ovarian secretions)
independently of sex chromosome complement (aside
from Sry) and to identify sex differences caused by the
direct effects of sex chromosome complement on non-
gonadal tissues. The essence of this model is that the Y
chromosome (here designated Yˉ) lacks the small region
encoding Sry, and a functional Sry transgene has been
introduced onto an autosome. XYˉ mice possessing the
Sry transgene (XYˉSry mice) have testes and are fertile
(XYM). Because Sry now segregates independently of
the sex chromosomes, crossing XYM with normal XX
female mice yields the four core genotypes: XX mice
with ovaries (XXF) or testes (XXM), and XY mice with
ovaries (XYF) or testes (XYM). Comparison of the FCG
progeny is a 2 × 2 comparison of individuals that are ei-
ther XX or XYˉ and have or lack the Sry transgene
(Table 2).
At the outset, it is important to establish that the XX
vs. XY phenotypic sex difference of interest is seen in
the FCG XXF vs. XYM comparison. Comparing the
phenotype of mice with or without Sry is a measure of
the effects of the Sry transgene: both the direct effects of
Sry on tissues themselves and the indirect effects caused
by testicular vs. ovarian secretions. Comparing XX and
XYˉ mice allows assessment of the differential effects of
sex chromosome complement (XX vs. XYˉ). Importantly,
the comparison of XX and XYˉ in this model identifies
differences that are common to the XXF vs. XYF and
XXM vs. XYM comparisons and excludes differences
found in normal XX females vs. XY males that are due
to the Sry expression in males. The FCG does not separ-
ate the potential direct effects of Sry outside of the
gonads from the indirect effects that are a consequence of
Sry triggering testicular development, because the direct
effects and hormonal effects are confounded (Table 2).
Although the FCG cross has been used successfully to
identify a number of direct SCEs [12, 45, 46], investiga-
tors should be aware of the caveats considered in the
next section.
Table 2 Progeny of FCG Cross XX x XYˉSry (XYM)
Genotypes Gonads NPX NPY [−Sry] Sry PAR [−Sts] Sts Xm Xp Xi
XXF F 2 0 0 2 2 1 1 1
XXM M 2 0 1 2 2 1 1 1
XYF F 1 1 0 2 2 1 0 0
XYM M 1 1 1 2 2 1 0 0
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Important caveats relating to the FCG cross
Genetic background
FCG mice have been generated on various genetic back-
grounds—C57BL/6J inbred [47, 48], SJL inbred [49], C3H/
He x C57BL/6 hybrid with a fixed B6 X [38], and “MF1”
outbred with a fixed (“uniform”) MF1 X [50] (see “Genetic
variability of NPX” section). However, with the C57BL/6J
inbred FCG stock now available from the Jackson Labora-
tory (strain 010905) and difficulties with availability and
maintenance of the F1 and outbred strains, the Jackson
Laboratory strain is becoming the strain of choice.
Potential differences in expression between endogenous
and transgenic Sry
The key features of the FCG cross are (i) the deletion of
Sry from the Y (this Yˉ, originally derived from the strain
129/SvEv-Gpi1c) and (ii) the Sry transgene [44]. The Sry
transgene is located on chromosome 3 and is estimated to
be present in 12–14 copies, although they may not all be
functional [51]. Thus, the transgene may not have expres-
sion levels that are identical to those of the endogenous
Sry encoded by the Y chromosome [52]; furthermore,
there may be some ectopic expression relative to the en-
dogenous Sry. If the differences between XX females and
XY males depend on whether the Sry gene is wild-type
(WT) or transgenic (as in FCG males), then the FCG
model could misrepresent the normal differences in WT
XX vs. XY cells. However, the XX vs. XYˉ difference in the
FCG model is assessed both in the presence and absence
of the transgenic Sry, so that XX vs. XYˉ differences that
occur under both conditions are likely to be robust and
independent of Sry effects. To avoid the possibility of any
abnormal effects of the transgene, some studies compare
only XX and XYˉ females [53]. Furthermore, elements of
the XX vs. XYˉ differences found in FCG mice (for ex-
ample, the effects of one vs. two X chromosomes) can be
potentially confirmed using the XY* model that has no
transgene (see section on “Linking direct SCEs to a spe-
cific component(s) of the XX or XY complements” below)
[47, 48].
Genetic variability of NPX
When comparing the FCG genotypes, the NPX segments
in XX and XY mice should be genetically identical, so that
group differences attributed to sex chromosome comple-
ment (XX vs. XYˉ) are not confounded by NPX allelic
differences. In inbred strains such as C57BL/6 (“B6”) or
SJL, all the Xs are identical so the requirement for genetic
uniformity of NPX is met.
Differences in hormonal status in groups with the same
type of gonad
Another issue for the FCG model is that the two groups
of gonadal females and the two groups of gonadal males
differ markedly in their fertility, which could be linked
to hormonal differences. XYF on a B6 background are
almost always sterile (PSB unpublished data), although
on the MF1 outbred background, they do breed [54, 55].
Using the MF1 strain, it has been shown that it is a
combination of a markedly reduced oocyte pool together
with the expression of the Y-encoded transcription factor
ZFY2 in the oocytes leading to impaired development of
embryos prior to implantation, which severely limits the
fertility [55]. Nevertheless, estrous cycle data collected in
association with an FCG behavioral study [56] revealed
that estrous cycles are still present in ~85–90% of MF1
XYF at 6–8 months of age (William Davies, personal
communication), demonstrating that the majority of
XYF ovaries are hormonally competent. FCG XYF on
the B6 background have also recently been shown to
cycle when assayed at 35–65 days of age and have simi-
lar levels of estradiol to XXF. However, ovaries are
smaller in XYF than in XXF, and gonadotrophin levels
are elevated in XYF relative to XXF especially after day
65, suggesting ovarian dysfunction or premature failure
in XYF relative to XXF [9].
XXM are sterile with very small testes. This is because
the presence of two X chromosomes in the germ cells
leads to early spermatogenic failure [57, 58]. Neverthe-
less, XXM testes secrete androgens and the levels in
XXM and XYM have been reported to be equivalent in
adults [9, 52, 59, 60]; furthermore, numerous traits
sensitive to testosterone levels during development are
similar in XXM and XYM [44, 51, 61, 62]. For example,
the anogenital distance is the same in XXM and XYM
mice, and smaller in XXF and XYF relative to males,
suggesting that the prenatal androgen levels that
masculinize anogenital distance are similar in the XXM
and XYM [51]. XXM are also reported to have elevated
levels of follicle-stimulating hormone (FSH) relative to
XYM from before puberty to age 5 months [9]. However,
numerous studies have compared levels of testosterone
in adult XXM and XYM, or of estradiol in adult XXF
and XYF, and none has uncovered differences in plasma
gonadal steroid levels to date [9, 52, 59, 60, 63–65].
Despite evidence against XX vs. XY differences in
levels of circulating gonadal hormones, it is impossible
to rule out differences that might occur before birth or
in environmental conditions (stress, disease) when hor-
mone levels are not measured. What steps can be taken
to avoid the potential confound between these hormone
differences and sex chromosome complement differ-
ences? One approach that has been used is to gonadec-
tomize the mice (with or without equivalent hormone
replacement) so that the phenotype of interest can be
measured in mice that have the same levels of gonadal
hormones at the time of measurement. However,
although this approach controls for acute (“activational”)
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effects of hormones, it does not control for long term
(“organizational”) effects of hormones prior to the gonadec-
tomy [66]. Nevertheless, the FCG model allows an inde-
pendent assessment of the importance of organizational
effects of gonadal hormones, because the comparison of
gonadectomized males and females tests for the importance
of permanent effects of testicular vs. ovarian secretions. In
some cases, robust differences between gonadectomized
XX and XY mice have been found in the absence of
evidence of organizational hormonal effects [47, 48, 67, 68],
so that it is difficult to attribute those XX vs. XY differences
to within-sex differences in the levels of gonadal hormones.
Investigators may wish to measure phenotypes of gonadally
intact FCG mice to test the effects of sex chromosome
complement in the presence of ovaries or testes but are
encouraged to test gonadectomized mice as well (with or
without treatment with equal levels of gonadal hormone at
the time of testing) to attempt to control hormone levels
experimentally to better understand their role (see “FCG
outcomes” section).
FCG outcomes
In what follows, we define sex difference to be a differ-
ence in phenotype between WT XX females and WT
XY males that has been confirmed to be present in the
FCG XXF vs. XYM comparison. The four outcomes
correspond to outcomes of a 2 × 2 ANOVA with factors
of Sry (absent or present, same as gonadal female vs.
male) and sex chromosome complement (XX vs. XY)
(Fig. 2).
1. An XX vs. XYˉ difference in phenotype occurs in
both gonadal females and gonadal males (Fig. 2a),
which is equivalent to the original sex difference
found in WT mice. This outcome in the ANOVA is
a main effect of sex chromosome complement in the
absence of a main effect of Sry or an interaction.
This result suggests that the sex difference is due to
a direct SCE that is independent of Sry/gonadal
secretions. Although this conclusion is satisfactory
by itself, further tests are prudent, both to confirm
the direct SCE in a different model (e.g., in XY*
progeny, see next section on “Linking direct SCEs to
a specific component(s) of the XX or XY
complements”) or to test further for effects of
gonadal hormones to rule them out. For example, it
is possible to gonadectomize mice with or without
hormone replacement, to rule out subtle hormonal
confounds. Sex differences are rarely totally
unaffected by gonadal hormones.
2. A phenotypic difference is found between mice
differing in Sry/gonadal type, which is irrespective of
sex chromosome complement and equivalent to the
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Fig. 2 Possible outcomes of experiments using the four core genotypes to assess the effects of sex chromosome complement (XX vs. XYˉ) and
gonadal sex (males M vs. females F) on a dependent variable (DV)
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two-way ANOVA, this is a main effect of Sry/go-
nadal type in the absence of effects of sex chromo-
some complement (Fig. 2b). This result implies that
the original sex difference is exclusively an effect of
gonadal type (testicular vs. ovarian secretions) and/
or a direct effect of Sry acting outside the gonads.
Gonadectomy of FCG mice will confirm whether or
not there is hormonal involvement and can help dif-
ferentiate between activational and organizational
hormone effects [67, 69].
3. The sex difference is independently influenced by
Sry/gonadal type and by a direct SCE. This result
leads to a significant main effect of both factors in
the two-way ANOVA without a significant interaction
(Fig. 2c). To investigate the hormones involved, and
their times of action, one would perform further
studies to manipulate the levels of gonadal hormones
in both sexes either in adulthood or during early
phases of development. A number of organizational
effects are known to occur postnatally and thus can
be revealed by gonadectomy, and prenatal
organizational effects may be documented by
manipulating hormone levels in utero.
4. The sex difference is caused by an interaction of sex
chromosome complement and Sry/gonadal type, as
is shown by a statistically significant interaction of
the two factors in the two-way ANOVA (Fig. 2d)
[47]. This result means that both factors contribute
to the sex difference but that the effect of each
factor depends on the level of the other factor
(e.g., the effect of testicular secretions depends on
whether the mouse is XX or XYˉ). Further experiments
(gonadectomy, hormone treatments, etc.) would define
the hormones involved and their times and sites of
action in XX vs. XYˉ mice, and mechanistic
experiments would define the molecular pathways
influenced by both factors.
Linking direct SCEs to a specific component(s) of
the XX or XY complements
The strategies outlined below are based on the assump-
tion that the direct SCEs are a consequence of differ-
ences in gene expression resulting from the difference in
sex chromosome complement. If the tissue underlying
the direct SCE can be identified with a high degree of
confidence, then a case may be made for using RNA
sequencing (RNAseq) on this tissue from the FCG in
order to provide a list of candidate genes at this stage
(see sections below beginning with “Candidate genes for
direct SCEs). We will refer to this tissue as the “target
tissue.” The candidate genes will be either on the NPX
or NPY. The following crosses provide a logical ap-
proach to determining the extent to which NPX and/or
NPY genes are responsible for direct SCEs.
Important: see Additional file 1, which provides the
details of the three-generation breeding strategy needed
to produce the fathers for Cross B. This involves progeny
from Cross C.
Identifying NPX and NPY effects using Cross A: XX♀ x XY*♂
This cross is the best starting point for identifying
potential NPX and NPY effects. The fathers have a
variant Y chromosome (denoted Y*) that leads to the
generation of a minute X chromosome derivative (termed
Y*X for historical reasons) composed of a complete PAR,
no NPY, and a small subsegment of NPX (NPX+) cur-
rently estimated to be less than 1% of the total NPX
(Table 3, Fig. 3) [70, 71]. As we shall see, the resulting
XmY*X female progeny are used for Cross C that enables
NPX dosage effects to be distinguished from NPX paren-
tal imprinting effects.
1. Identifying an effect of NPX (two vs. one copies).
A comparison of XmXp vs. XmY*X is a test of the
effect of the number of NPX segments (2 vs. 1),
keeping the number of PARs = 2.
Cross A also tests for an NPX effect in the
comparison of the two gonadal male groups, XmXpY*
with XmY*, although in this case, the comparison
deviates from the precise genetic conditions found
in the XX-XY comparison in three ways: the pres-
ence of NPX+ in XmY*; single copy of Sts in XmY*
instead of two copies found in XX or XY; and three
copies of the region of the PAR that does not
contain Sts, instead of two in XX or XY (Table 3).
If the phenotypic difference between females containing
one vs. two copies of NPX is similar to the difference
between males with one vs. two copies of NPX, these
deviations from normal XX and XY are generally
considered minor [47].
2. Identifying an NPY effect.
The effect of NPY can be detected in a comparison of
XmY*X vs. XmY* and XmXp vs. XmXpY*. These
Table 3 Progeny of Cross A: XX x XY*
Genotypesa Gonads NPXb NPY Sry PAR [−Sts]b Sts Xm Xp Xi
XmO (rare)c F 1 0 0 1 1 1 0 0
XmY*X F 1+ 0 0 2 2 1 0 0
XmXp F 2 0 0 2 2 1 1 1
XmY* M 1+ 1 1 3 1 1 0 0
XmXpY* M 2 1 1 3 1 1 1 1
aParental sources of the X chromosomes (Xm: maternal; Xp: paternal) are
included in Tables 4, 5, and 6, since these crosses are also used to identify
effects of parental X imprinting
bFigure 3 illustrates the structures of the Y*, XY*, and Y*X chromosomes and
the gene content of Y*X that includes the minute + subsegment of NPX that is
also present in Y*. Note that the Y* and XY* PARs have a duplication of PAR
regions A and B but lack PAR region C that encompasses the Sts locus
cXmO are rare (~1% [75])
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comparisons are confounded with differences in the
number of PAR segments as shown in Table 3. The Y*
also has a different strain origin (LT/Sv) from that of
the Yˉ from the FCG (strain 129/SvEv-Gpi1c). Thus, if
the investigator finds no effect of the Y chromosome
in this cross, it could be a Y chromosome strain
difference. On the other hand, if a Y effect is found,
then one can conclude that at least some Y
chromosomes create a difference relative to XY*X
mice, which therefore may explain the original sex
chromosome effect in FCG. Because the Y*
chromosome encodes Sry, the NPY effect could be the
result of testicular secretions; that possibility will
already have been evaluated by a study of FCG mice,
which will indicate whether the phenotype is
influenced by gonadal hormones or not. If Cross A is
used without knowledge of the outcomes from studies
of FCG mice, it will not be possible to eliminate the
hormonal confound of the Y* chromosome.
3. Interpretation of outcomes
(a)NPX copy number effect only. The different
effects of one vs. two copies of NPX can be
caused by dosage differences (inherently higher
expression of genes that escape X inactivation
in XX than XY) or by X imprinting effects
(different expression levels of paternally vs.
maternally imprinted X chromosomes).
Importantly, this cross tests for an effect of
NPX copy number both in gonadal males (with
Sry) and gonadal females (without Sry). If an
NPX copy number effect is found in Cross A
and in FCG mice, the results indicate that the
effect does not depend on the Sry transgene in
the FCG model.
Fig. 3 Sex chromosome structure diagrams related to Cross A (XY* model [70]). Sections of the sex chromosomes have been deleted to allow
expansion of other regions for illustration. For the WT sex chromosomes, the PAR is illustrated in three sections†, one of which contains Sts. The
minute + subregion of the NPX (<1% of the total NPX), adjacent to the PAR, is shown as a bracketed region within the entire NPX for the X and
XXY* chromosomes, and in yellow for the Y* and Y*X chromosomes. The Y* chromosome has an X centromere and the plus (+) region of NPX
adjacent to a unique duplicated PAR that nevertheless lacks Sts (ΔPAR). The X centromere (X CEN) is the functional centromere, whereas the Y
centromere is inactive (Y CEN). The Y* chromosome undergoes abnormal recombination with the X chromosome to produce (1) the long XY*
chromosome that is an end-to-end fusion of NPX and NPY with the ΔPAR lacking Sts and (2) the minute Y*X chromosome with a normal PAR
and the plus (+) region of NPX. The gene map for the Y*X illustrates the approximate positions of genes transcribed from the forward strand
(black rectangles) or reverse strand (lines), with the centromere (orange) and the plus (+) region of NPX (yellow) color coded. In effect, Y*X is an X
chromosome with a massive NPX deletion running from a region thought to be just proximal to Msl3 and ending within the Sstx/Spin2 multi-copy
cluster adjacent to the telomeric X centromere [22, 72, 118–120]. The dividing line between NPX+ and the rest of NPX is not known precisely but is on
the centromeric side of Msl3 [72]. This figure updates and corrects earlier versions [50, 121].
† The PAR sections A–C were originally defined by mapping using the XY* model [71]: A, the terminal section of Mid1/Fxy (including the last three
exons) that lies within the PAR [122]; B, the region that contains the multi-copy locus DXYHgu1 [123]; and C, the region containing Sts [124]. It is now
known that Erdr1 is located in the PAR just distal to Mid1 and is retained in Y* and XY*—thus, it maps to the PAR region B [125]. On the other hand,
Asmt is absent in Y* and XY*—thus, it maps to the PAR region C [126]. Sts is thought to be distal to Asmt, but this has not been confirmed
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(b)NPY effect only. The SCE is attributed to NPY
genes. Numerous NPY genes have an X “partner”
gene that theoretically has a similar function (see
section on “Candidate genes for direct SCEs”
below). If the NPY effect is caused by one of
these genes, the implication is that the NPY gene
has an effect distinct from its X partner.
(c)NPX and NPY effects. In this case, it is
possible that X and Y partner genes are
involved, with the X gene escaping X
inactivation [50]. Alternatively or additionally,
the NPX effect could be due to imprinting.
4. Advantages and drawbacks
(a)This a relatively simple cross that enables
comparisons to be made quickly and
economically.
(b)Some of the XmY*X female offspring can be
utilized as mothers for Cross C that enables
parental X imprinting effects to be identified.
(c)It has the minor disadvantage that the Y*
chromosome has a different strain origin to that
in the FCG cross.
(c)It has the disadvantage that Y* encodes Sry, and
thus all NPY-bearing mice are gonadal males, and
differ hormonally from gonadal females that lack a
Y chromosome. Thus, it does not test for an effect
of NPY independent of its effect on gonadal
secretions, unless prior studies of FCG mice
indicate that the phenotype is not sensitive to
gonadal hormones. This disadvantage is remedied
in Cross B.
(d)NPX is subject to X inactivation in XmXp. A
minor concern is that in XmY*X the small NPX+
segment present on Y*X is exempt from X
inactivation because it does not include Xist.
Genes in this segment are therefore expected to
be expressed from both the X and Y*X
chromosomes [72]. In contrast, the same segment
in XmXp is expected to undergo random X
inactivation and thus be expressed only from the
active X chromosome. If these genes are
expressed in the target tissue of the direct SCE, it
is therefore likely that they will be expressed
higher in XY*X than XX. However, only a few
known genes are encoded by NPX+ (Fig. 3)
and they can be discounted if these genes
show no difference in expression in the
relevant target tissue.
Identifying NPX and NPY effects using Cross B: XX♀ x
XYˉY*XSry ♂
As we have seen, there are a number of drawbacks to
Cross A when it is used to attribute direct SCEs to NPX
or NPY. This is particularly the case when the FCG
outcomes indicate that gonadal hormones affect the direct
SCE [50]. Cross B provides a more sophisticated assess-
ment of potential NPX and NPY effects by bringing to-
gether the Yˉ chromosome and Sry transgene from the
FCG cross, with the Y*X chromosome generated by Cross
A. Cross B is useful for balancing the number of PARs
when assessing the effect of NPX dose, for example, in the
comparison XX vs. XY*X. The cross produces the seven
genotypes shown in Table 4, each with or without the Sry
transgene, thus 14 genotypes in all. However, it is the
three female/male pairs of genotypes with two sex chro-
mosomes that are of primary interest. (The fathers for this
cross are generated by mating XmXpY*X females from
Cross C to XYˉSry males—see Additional file 1).
Cross B allows the following comparisons or
interpretations:
1. Confirming the sex chromosome complement effect
identified in the FCG cross
The offspring of this cross include all the genotypes
from the FCG cross, so the outcomes relating to XmXp
(F or M) vs. XmYˉ (F or M) should be replicated here.
2. Identifying an effect of NPX (two vs. one copies)
A comparison of XmXp vs. XmY*X is a within-sex test
(i.e., the comparison can be made either in gonadal
females or in gonadal males) of the effect of the
number of NPX segments (two vs. one), keeping the
number of PARs = 2.
3. Identifying an NPY [−Sry] effect.
A comparison of XmY*X vs. XmYˉ provides a
within-sex test of the effect of NPY [−Sry],
keeping the number of PARs = 2.
4. Interpretation of outcomes
(a)NPX copy number effect only. The different
effects of one vs. two copies of NPX can be
caused by dosage differences (inherently higher
expression of genes that escape X inactivation in
XX than XY), or by X imprinting effects, as for
Cross A. Importantly, this cross tests for an effect
of NPX copy number both in gonadal males (with
Sry) and in gonadal females (without Sry).
(b)NPY [−Sry] effect only. The SCE is attributed to
NPY genes. Many NPY genes have an X partner
gene that theoretically has a similar function (see
section on “Candidate genes for direct SCEs”
below). If the NPY effect is caused by one of
these genes, the implication is that the NPY gene
has an effect distinct from its X partner.
(c)NPX and NPY effects. In this case, it is
possible that X and Y partner genes are
involved, with the X gene escaping X
inactivation [50]. Alternatively or additionally,
the NPX effect could be due to imprinting.
5. Advantages and drawbacks
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(a)The fathers for this cross can be bred by mating
XmXpY*X females from Cross C to XYˉSry (FCG)
males (Additional file 1).
(b)This cross allows an elegant comparison of mice
with two X chromosomes, one X chromosome,
or one X and one Y chromosome (all with two
PARs), each of which are produced as males or
females. It is the only cross to achieve this degree
of balancing of sex chromosome complement and
gonadal sex. It also allows more comparisons
than any other cross, to assess effects of NPX
number, NPY, and gonadal sex.
(c)Unlike Cross A, in this cross, NPY effects are not
confounded by gonadal sex, and thus hormonal
and NPY effects are more easily separated. NPY
effects can be detected that occur in both gonadal
males and gonadal females.
(d)With 14 possible genotypes, the breeding is
time-consuming and expensive.
(e)Differentiating among the genotypes is difficult
using chromosome spreads because the Y*X is
minute and easily missed; quantitative genomic
PCR can confirm the presence or absence of Y*X
[73, 74] (Additional file 2).
(f ) As for Cross A, a minor concern when detecting
an NPX effect is that the small NPX+ segment in
XmY*X is present on both sex chromosomes but
does not undergo X inactivation, in contrast to
the same segment in XmXp that is expected to
undergo random X inactivation. If the NPX+
genes are expressed in the target tissue of the
direct SCE, it is likely that they will be expressed
higher in XY*X than in XX. Similarly, when
detecting an NPY effect, the absence vs. presence
of NPY [−Sry] is confounded with the presence
vs. absence of NPX+ (Fig. 3). However, NPX+
encodes only a small number of genes (Fig. 3)
and they can be discounted if these genes
show no difference in the expression in the
relevant target tissue.
Detecting effects of X chromosome imprinting
An NPX copy number effect identified by Cross A or B
can be due to X genes that are exempt from the tran-
scriptional silencing of one X due to random X inactiva-
tion [28]. In this case, transcript levels for these X genes
are higher in XmXp than in XmY. An NPX copy number
effect can also be due to parental X imprinting (see sec-
tion on “Candidate genes for direct SCEs” below). For
some X genes, this results in higher transcription from
the Xp and thus elevated transcription in XmXp relative
to XmY (an expression pattern similar to that for X
genes that escape X inactivation); for other imprinted X
genes, it results in higher transcription from the Xm and
thus elevated transcription in XmY relative to XmXp.
However, in either case, Xm/Xp transcript ratios in the
XmXp females can vary from one tissue sample to an-
other if there is patchiness of random X inactivation in
the target tissue sample (as exemplified in [30]). Here,
we compare crosses that can identify effects arising from
X imprinting and that compare female XmY*X (Cross A,
Table 3) vs. XpY*X (Cross C, Table 5) in order to avoid
the inherent variability of Xm vs. Xp expression associ-
ated with random X inactivation in XmXp.
An effect of imprinting on X genes is detected by
comparing female offspring of Cross A (XX x XY*) with
those of Cross C (XY* x XY). As we have seen (Table 3),
Cross A generates XmY*X females with a maternally
imprinted X, together with XmXp female controls. In
Cross C (Table 5), the XmY*X females from Cross A are
mated to XY males to produce XpY*X females with a pa-
ternally imprinted X, together with XmXp female con-
trols. For reasons that do not concern us here, Cross C
also generates some XmXpY*X females and XmYY*X
males (Table 5). The important difference in Cross C
relative to Cross A is that the XY*X progeny carry a pa-
ternal X rather than a maternal X. This comparison is of
mice that differ genetically only in the imprint on the
single X chromosome.
1. Detecting Xp vs. Xm imprinting effects
Table 4 Progeny of Cross B: XX x XYˉY*XSry
Genotypesa Gonads NPXb NPY [−Sry] Sry PAR [−Sts] Sts Xm Xp Xi
[XmO rare] F or M 1 0 0F or 1M 1 1 1 0 0
XmY*x F or M 1+ 0 0F or 1M 2 2 1 0 0
XmXp F or M 2 0 0F or 1M 2 2 1 1 1
XmYˉ F or M 1 1 0F or 1M 2 2 1 0 0
[XmXpY*X] F or M 2+ 0 0F or 1M 3 3 1 1 1
[XmYˉY*X] F or M 1+ 1 0F or 1M 3 3 1 0 0
[XmXpYˉ] F or M 2 1 0F or 1M 3 3 1 1 1
aEach genotype can be with or without Sry. Parental sources of the X chromosomes are indicated (Xm: maternal; Xp: paternal)
bFigure 3 includes the structure and gene content of the Y*X chromosome
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If an NPX effect detected in Cross A is at least in
part caused by a parental imprint of the X
chromosome, then a similar or enhanced difference
should be detected when comparing XmY*X from
Cross A with XpY*X from Cross C.
2. Checking for maternal effects
Because these differences in imprint are potentially
confounded with maternal effects (differences
between crosses in maternal behavior, uterine
effects, or other environmental differences), it is
prudent to compare the XmXp female progeny
between the two crosses (A vs. C) as a check for
confounding variables. If the XX females from the
two crosses are similar, the confounding variables
would seem not to be having a significant effect.
3. Advantages and drawbacks
(a)These crosses have the advantage that they are
both feasible on a B6 inbred background [75, 76].
As previously observed [75], from Cross C, there
are no surviving XpOs, but ~11% of the offspring
are XpY*X (Rhonda R. Voskuhl, personal
communication).
(b)Differentiating among the genotypes can be
difficult using chromosome spreads because the
Y*X is minute and easily missed; quantitative
genomic PCR can confirm the presence or
absence of Y*X [73, 74].
(c)There is evidence from the study of embryos
from XO females that maternal X monosomy
has deleterious effects on development of
preimplantation embryos [55, 77]; these
effects could come into play in Cross C. See
Additional file 3 for crosses E and F that avoid
this potential confound.
(d)XpO embryos are developmentally retarded in
early pregnancy whereas XmO embryos are not
[10, 75, 77–79]. This Xp effect would be expected
to affect XpY*X embryos and thus is a potential
confound when identifying imprinting effects.
However, it appears to be ameliorated by the
addition of Y*X.
(e)The yield of XpY*x progeny in Cross C in B6 is
low because of small litters. Probably because of
the XpO death in utero, the XmY*X mothers often
experience birthing problems leading to the death
of viable XpY*X fetuses. A potential solution
might be to set up timed B6 XmY*X x XY matings
and timed F1 or outbred strain matings known to
provide reliable foster mothers. Caesarian section
and fostering can then be done when the B6
mothers are due to litter. There are various
well-established humane husbandry protocols for
this fostering procedure.
Summary: a pragmatic approach
Taking into account the advantages and drawbacks
discussed above, the most feasible strategy to investigate
sex chromosome complement effects is as follows: (1) Es-
tablish a sex difference in gonadally intact XX females vs.
XY males. The difference is most likely caused by the ef-
fects of gonadal hormones. (2) If experiments such as those
recommended by Becker et al. [68] suggest that the sex dif-
ference is not caused entirely by differences in levels of go-
nadal hormones, one can use the FCG mice to detect sex
chromosome complement effects that depend on, or are in-
dependent of, gonadal hormones. (3) If a sex chromosome
complement effect is found in FCG mice, then Crosses A
and/or B can be used to provide information as to whether
the effect is caused by differences in NPX complement
and/or the presence vs. absence of NPY. Cross A is easier
than Cross B. Cross B is a more sophisticated cross for
identifying NPX and NPY effects and is required to detect
NPY effects if FCG outcomes make it difficult to separate
hormonal and sex chromosome effects with Cross A. (4)
Studies using Crosses A and C will assess the importance
of X imprinting vs. NPX dosage. Together, these ap-
proaches will narrow down the X or Y candidate genes to
be tested further as discussed in the next few sections.
Candidate genes for direct SCEs
Here, we provide an overview of the sex chromosome
genes whose differential expression between XX females
Table 5 Progeny of Cross C: XY*X x XY
Genotypesa Gonads NPXb NPY [−Sry] Sry PAR [−Sts] Sts Xm Xp Xi
[XpO]c F 1 0 0 1 1 0 1 0
XpY*x F 1+ 0 0 2 2 0 1 0
XmXp F 2 0 0 2 2 1 1 1
XmY M 1 1 1 2 2 1 0 0
[XmXpY*X]d F 2+ 0 0 3 3 1 1 1
[XmYY*X] M 1+ 1 1 3 3 1 0 0
aParental sources of the X chromosomes are indicated (Xm: maternal; Xp: paternal)
bFigure 3 includes the structure and gene content of the Y*X chromosome
cOn a B6 background, these females die in utero [75]
dThese XmXpY*X females are mated to XYˉSry males in order to produce the XYˉY*XSry males used for Cross B (see Additional file 1)
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and XY males may lead to direct SCEs in the target
tissue in which the direct SCE originates. These com-
prise the following: (i) X genes that have parental im-
prints that lead to differential expression between males
and females in the target tissue; (ii) X genes that escape
X inactivation in the target tissue, an important group of
which are X genes that have functionally similar partner
genes on the Y chromosome (X-Y gene pairs that are
termed “gametologs”); (iii) Y genes that are expressed in
the target tissue of XY males.
Parentally imprinted X genes
Classically, parentally imprinted genes were defined as those
that were expressed only from the paternally derived chromo-
some or from the maternally derived chromosome. Recently,
it has been established that parental imprinting can also lead
to different levels of expression between the two parentally
imprinted chromosomes. These two types of imprinting are
now referred to as “canonical” and “noncanonical” imprinting,
respectively [80]. There are two examples of canonical X gene
imprinting that are relevant here. Firstly, there is the canon-
ical imprinting of the Xist locus (reviewed by [32, 81]). This
results in Xist only being expressed from the paternal X of
XX embryos, beginning at the two-cell stage, which leads to
the progressive inactivation of the paternal X during early
cleavage stages. This paternal X inactivation is then removed
from the blastocyst inner cell mass (the cells that form the
body of the embryo) and is replaced with random Xist-medi-
ated X inactivation, whereas the extra-embryonic tissues that
contribute to the placenta retain paternal X inactivation [82,
83]. These Xist imprinting effects have to be borne in mind
as a potential confounding factor. For example, paternal X
imprinting leads to an early developmental retardation of
XpO embryos, which might impact subsequent development
[10, 78, 79, 84]. However, this retarding effect of Xp imprint-
ing is much reduced in the context XmXp female vs. XmY
male (or female) comparisons [8]. The only other canonically
imprinted X genes that have been identified in mice are
members of the Xlr gene family that are expressed from the
maternal X; mice with only a paternal X exhibit impaired
cognitive behavior [80, 85–87].
On the other hand, the study of Bonthuis et al. [80]
identified 198 noncanonically imprinted X genes with
170 of such genes identified in a single tissue, the hy-
pothalamic arcuate nucleus. In contrast to canonically
imprinted genes, the imprinting was very tissue-specific.
Clearly, this class of genes has the potential to make a sig-
nificant contribution to X chromosome-associated direct
SCEs. Intriguingly, there is a significant preponderance of
X genes showing higher expression from the maternal X
across all four tissues analyzed—see Figure S5A and D of
Bonthuis et al. [80]. The impact of noncanonical imprint-
ing on SCEs will increase as the expression from the two
parental alleles becomes more disparate.
X inactivation escapees
During the evolution of the X-Y chromosomes from
their autosomal progenitors, there was a progressive loss
of Y genes, while their X partners became subject to X
inactivation to balance gene expression between males
and females. However, a number of Y genes escaped
attrition and the survivors are predominantly widely
expressed regulatory genes. It is assumed that dosage
sensitivity for these genes led to the retention of the Y
copies because mutation of the Y gene was strongly dele-
terious so that that mutant Y chromosome was not
passed on. Retention of the Y gene was associated with
escape from inactivation of the X copies, thus retaining
two expressing copies in males (X + Y) and females (X +X),
preventing a deleterious level of expression relative to inter-
acting autosomal genes [19, 20]. (See Table 6 for the X-Y
gene pairs in mice and humans).
An important caveat is that the set of surviving Y genes
varies among different groups of mammals. In mice, there
seems to have been a tendency for the X copy of such
gene pairs to become subject to X inactivation, and for the
Y copy to diverge in sequence and acquire testis-specific
functions (Tables 6 and 7). Also, the Y copies of the four
X-Y gene pairs where the X is not subject to X inactivation
are not essential in mice since XmO mice are viable;
indeed, during fetal development, they are slightly ahead
of XX fetuses and equivalent to XY fetuses [10]. This is in
marked contrast to the lethality of non-mosaic human
XOs [88]; this may reflect the larger number (14) of X
inactivation escapees among X-Y gene pairs for which
human XOs are dosage deficient [19]. Consequently, in
mice, there are only four X partner genes that are clear X
inactivation escapees as compared to 14 in humans.
Aside from these four X inactivation escapees that
have Y partner genes, a number of other X genes show
some degree of escape from X inactivation in vivo, and
this escape can be tissue specific. The most recent
study identified 34 of such genes, giving a total of 38
escapees—approximately 7% of mouse X genes [89].
NPY genes
Because NPY genes are only expressed in males, any NPY
gene could potentially contribute to a direct SCE that is
identified using the FCG. A comprehensive compendium
of the mouse Y gene content has recently been published
[22]. Because FCG analyses often seek to shed light on
human sex differences, in Table 7, we present the mouse
Y gene complement alongside a subset of the human Y
gene complement. The omitted human Y genes are those
that have been “acquired” by the human Y but not by the
mouse Y—for the most part, expression of these genes is
restricted to spermatogenic cells [19, 20]. Similarly, the
mouse has acquired genes that are not represented on the
human Y, and the expression is thought to be restricted to
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spermatogenic cells; as such, they are unlikely to be
involved in direct SCEs. Some of these genes are present
in multiple copies and have multiple copy X gametologs.
These genes are thought to have been amplified as a
consequence of a post-meiotic X vs. Y genomic conflict
[22, 23, 90]. The remainders of the mouse and human Y
gene complements are termed “ancestral,” because they
comprise a group of genes that were present on the Y of
therian mammals at an early stage of Y chromosome evo-
lution; all of these genes had gametologs on the X
chromosome. Over time, some of the X and Y copies
diverged, and in other cases, Y genes were lost differen-
tially among mammalian groups. The mouse Y ancestral
gene complement now comprises nine distinct genes, one
of which (Zfy) has duplicated and one of which (Rbmy) is
estimated to have 30 copies; the human Y has retained 17
ancestral genes, seven of which are also on the mouse Y.
The nine ancestral mouse Y genes and the predicted char-
acteristics of the proteins they encode are listed in Table 7.
Identifying candidate genes that underlie direct SCEs
Key information for determining which genes might
underlie a direct SCE is their expression profile. RNA
sequencing (RNAseq) is the current method of choice
for documenting the transcriptome in specific tissues or
cell types. It has the potential to document the relative
abundance of all the transcripts present in a tissue sam-
ple—the detection of rare transcripts can be improved
Table 6 Mouse and human Y genes and X gametologs
Class Mouse Human
Y gene Copy no. X gene Xi? Copy no. Y gene X gene Xi?
Ancestral S1 Sry 1 Sox3 Yes 1 SRY SOX3 Yes
Rbmy 30 Rbmx Yes 1 RBMY RBMX Yes
[Aut.] HSFY HSFX
Rps4 Yes 1 RPS4Y RPS4X No
Ancestral S2 Uba1y 1 Uba1 Yes 1 UBA1 No
Kdm5d 1 Kdm5c No KDM5D KDM5C No
[Tspy1ps] Tspyl2 Yes TSPY1 TSPX Yes
Ancestral S3 Zfy1,2 2 Zfx Yes 1 ZFY ZFX No
Uty 1 Kdm6a No 1 UTY KDM6A No
Usp9y 1 Usp9x Yes 1 USP9Y USP9X No
Ddx3y 1 Ddx3x No 1 DDX3Y DDX3X No
Eif2s3y 1 Eif2s3x No 1 Notea EIF2S3X No
Amelx ? 1 AMELYb AMELX ?
Notec Eif1ax Yes EIF1AY EIF1AX No
Tmsb4 ? TMSB4Y TMSB4X No
Txlng ? TXLNGY CYorf15 No
Ancestral S4/5 Tbl1x Yes TBL1Y TBL1X No
[Aut.?] NLGN4Y NLGN4X No
[Aut.?] PRKY PRKX No
Acquiredd H2al2y 2 H2al2x 14
Prssly 1
Teyorf1 1
Rbm31y 2 Rbm31x 1
Sly 126 Slx,Slxl1 39
Ssty1,2 306 Sstx 11
Srsy 197 Srsx 14
Based on information from [19–22]
Aut. autosomal
aEIF2S3Y function replaced by an autosomally located EIF2S3X retrogene [127]
bAncestral S4 in [19]
cEif1ay function replaced by an autosomally located Eif1ay retrogene [127]
dMouse data only
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by increasing the sequencing coverage depth. While
RNAseq data for the relevant target tissue may be avail-
able for XY female vs. XY male comparisons, hormone
effects may modulate or nullify expression differences
linked to the direct SCE. RNAseq data from FCG mice
would help to uncover such effects. In the following sec-
tions, we outline how such transcriptome information
can be utilized to home in on the X and/or Y genes that
generate the direct SCE.
Identifying NPX genes that cause direct SCEs
Here, we consider strategies for identifying the genes
underlying a direct SCE when NPX (but not NPY) has
been implicated in Cross A or B. The first step is to use
the FCG RNAseq data to generate a list of X genes that
are differentially expressed in the target tissues of XXF
vs. XYF and/or XXM vs. XYM FCG mice, under condi-
tions in which the differences are unlikely to be caused
by gonadal hormones.
As we have seen, the most abundant may well be X
genes subject to non-canonical parental imprinting
effects. If such genes are involved in generating the
direct SCE, this should have been detected in the XmY*X
vs. XpYX (Cross A vs. C) comparison in the section
above entitled “Linking direct SCEs to a specific compo-
nent(s) of the XX or XY complements”.
(a)X gene transcript levels where XmY > XmXp (Table 8).
If the canonically imprinted Xlr genes are involved,
they will fall into this category. Other X genes falling
in this category are prime candidates for being X
genes with noncanonical imprinting that leads to
reduced expression of Xp relative to Xm. This is the
predominant form of noncanonical X gene
imprinting (see Figure S5A and D in [80]).
(b)X gene transcript levels where XmXp > XmY (Table 8).
This could be due to (i) the noncanonical imprinting
where there is greater expression of Xp relative to
Xm or (ii) to genes that escape X inactivation, in
particular, the four widely expressed mouse X
inactivation escapees Kdm5c/Smcx, Kdm6a/Utx,
Ddx3x, and Eif2s3x (Table 6) or the additional
escapees identified by in vivo studies [89, 91]. The X
escapees are among the genes most often found to
differ in XX vs. XY mice in microarray-based
transcriptome profiling on various adult tissues of
FCG mice (Arnold, unpublished), and these have
been repeatedly reported to be expressed higher in
XX than in XY mice [47, 48, 72, 92–97].
The X genes that exhibit expression differences com-
patible with the direct SCE identified in the FCG mice
would be prioritized for further study. The X genes
might first be ranked with respect to the fold difference
in the level of expression between the relevant FCG
genotypes (e.g., XXF vs. XYF), and/or by the p value of a
statistical test that estimates the reliability of the differ-
ence in the expression between groups. These candidate
genes could be further prioritized based on their known
characteristics and potential relevance to the phenotypes
under investigation. If necessary, candidate genes would
be checked using quantitative RT-PCR to confirm the
expected group differences. If the candidate NPX gene is
a reported X escapee, and is expressed higher in XX
Table 7 Mouse ancestral Y genes
Gene Protein function Expressiona Role [references]
Sry HMG box transcription factor Testis Triggers the fetal genital ridge to form a testis [3, 98, 99]
Rbmy, ~30 copies RNA binding motif protein Testis; brain, kidney Aids sperm morphogenesis [116, 128, 129]
Uba1y Ubiquitin-activating enzyme Testis; brain, kidney,
liver, skeletal muscle
Not known [130, 131]
Kdm5d (Smcy) Lysine specific demethylase Ubiquitous Has epigenetic effects by modifying histone H3. Interacts
with MSH5 during spermatogenesis [132, 133]
Zfy1,2 Zinc finger transcription factors Testis, skeletal muscle Enable meiotic quality controls, the completion of the
second meiotic division and sperm morphogenesis/function
[73, 74, 104, 108, 109, 134]
Uty Tetratricopeptide repeat protein
without the demethylase activity
of UTX/KDM6A (a demethylase)
Ubiquitous Involved in protein-protein interactions? [98, 99, 105, 135]
Usp9y Ubiquitin specific peptidase Testis, brain, kidney,
skeletal muscle
Loss of function in man leads to spermatogenic
impairment [136, 137]
Ddx3y Probable ATP-dependent RNA helicase Ubiquitous Not known [138]
Eif2s3y Subunit of elongation and initiation factor Ubiquitous Involved in protein synthesis. Supports spermatogonial
proliferation [100, 102, 139]
Data in italics indicate low transcript levels. For brain expression, also see [140]
aBased on RNAseq data [22]
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than in XY, as expected from its status as an escapee, its
importance as a gene causal to the SCE would be estab-
lished by comparing mice with one vs. two copies of the
gene. For example, if Ddx3x (Table 6) is the candidate,
one might compare WT XX mice (with two copies of
Ddx3x) with XX mice with a heterozygous knockout of
Ddx3x (one copy). If these groups of mice differ in the
phenotype showing the SCE, such that one vs. two cop-
ies of Ddx3x mimics the phenotypic effects of one vs.
two copies of NPX, then Ddx3x is a likely contributor to
the SCE. This experiment determines if dosage differ-
ences in Ddx3x alone are necessary to show the SCE. An
additional strategy is to add a transgene encoding Ddx3x
to an XO or XY*X mouse, to determine if the phenotype
is affected appropriately in mice with one copy vs. more
than one copy of the candidate X escapee. The trans-
genic add-in experiment aims to test if the dosage differ-
ences in the X escapee are sufficient by themselves to
mimic the SCE. The main caveat is that expression levels
of the transgene may be difficult to control depending
on its promoter, position effects, etc.
The experiments comparing Cross A vs. C may suggest
that the NPX effect is the result of imprinting. In this case,
transcriptome profiling may reveal either XX >XY or
XY > XX expression patterns (Table 8) and differences in
expression of transcripts in XmY*X vs. XpY*X. To provide
further strong support for an NPX imprinting explanation
of an SCE, one might measure the effects of parent of
origin on the epigenetic status of the candidate gene and
manipulate its expression to mimic the differences in
expression found in XmY*X vs. XpY*X, to demonstrate that
these differences in expression alone are necessary and
sufficient to mimic the SCE, at least in part.
The manipulation of NPX expression is best performed
in a tissue-specific manner, assuming that the tissue of
interest is known. For example, a floxed allele of the
candidate gene can be knocked down with a tissue-
specific Cre. Indeed, the use of tissue-specific knockdown
or overexpression may help determine the tissue in which
the candidate gene causes the SCE.
Identifying NPY genes that cause direct SCEs
Here, we consider strategies for identifying the genes
underlying a direct SCE when NPY (but not NPX) has
been implicated in Cross A or C. The first step is to
check the RNAseq data to provide a list of the Y genes
expressed in the SCE target tissue. Prioritizing the candi-
date genes may be possible based on the current infor-
mation about the function of the Y genes or their similar
X gametologs.
Given that only seven Y genes (Uba1y, Kdm5d, Uty,
Usp9y, Ddx3y, Eif2s3y, and Ssty2) have been shown to
be widely expressed in non-gonadal tissues as assayed
by RNAseq [22], the “prioritized list” of genes
expressed in a target tissue with a putative NPY-
linked SCE will likely be limited to one or a very few
genes. Thus, it makes sense to move on to the stage
of manipulating candidate Y gene expression in order
to demonstrate that the SCE of interest is a conse-
quence of the presence vs. the absence of a particular
NPY gene or genes. The basic approach is the same
as for candidate NPX genes discussed in the last sec-
tion “Identifying NPX genes that cause direct SCEs”.
Keeping other factors constant (e.g., sex chromosomes
and hormones), the investigator varies the presence/
absence of one candidate Y gene to determine if that
manipulation causes a phenotypic difference similar
to the SCE caused by the comparison of XX vs. XY.
Two basic approaches are available, either knocking
out the NPY gene in XY mice [98–101] and compar-
ing the knockout (KO) to WT XY or adding a trans-
genic copy of the candidate NPY gene in mice with
one X chromosome (e.g., XO or XY*X) and compar-
ing to controls without the transgene [73, 102]. It
would be best to start with global KO or transgenic,
where the genetic manipulation affects all tissues, but
tissue-specific gene targeting or transgenesis would
ultimately be a powerful demonstration of the effect
of the NPY in the target tissue. Transgenic lines en-
coding autosomal copes of NPY genes (Uty, Kdm5d,
Ddx3y, Usp9y, Ubely, and Eif2s3y) were developed in
the Burgoyne Lab and are being backcrossed to B6 in
the Arnold Lab.
It is possible but less likely that multi-copy NPY genes ac-
count for the SCE. Manipulating these genes is more prob-
lematic. One option is to knock down the expression using
a transgene that delivers small interfering RNAs such as has
been successful for the multi-copy NPYgene Sly [103].
Table 8 Predicted expression of imprinted X genes







FCG: XmXp < XmY
Cross A: XmY*X = XmY* > XmXp = XmXpY*
Cross B: XmY > XmXp > XpY*X







FCG: XmXp > XmY
Cross A: XmY*X = XmY* < XmXp = XmXpY*
Cross B: XmY < XmXp < XpY*X
Cross C: XmY* = XmY*X < XmXp
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Investigators who have obtained evidence for NPY
involvement might consider using crosses in Additional
file 4 to map the NPY genes that underlie the direct
SCE to specific regions of the Y. The first cross
involves a commercially available Sxra mutation that
involves translocation of Y short arm (Yp) genes to the tip
of the X or Y PAR and will establish if the SCE involves
Yp genes that map to Sxra [104]. If this is not the case, the
second cross utilizing a Y deletion (Yd1) should provide
confirmation that multi-copy NPY genes are involved. A
contact e-mail is provided in Additional file 4 for those
wishing to use this Yd1 deletion.
Interpreting cases of dual NPX and NPY effects
obtained with Cross A or B
Here, we consider the strategies for identifying the genes
underlying a direct SCE when NPX and NPY have simi-
lar effects in Cross A and/or B. The prime candidate
genes are the ancestral X-Y gene pairs Uba1y/Uba1,
Kdm5d/c, Zfy/x, and Uty/x (Utx A.K.A. Kdm6a),
Usp9y/x, Ddx3y/x, and Eif2s3y/x; Table 6). As discussed
in the section above, “Candidate genes for direct SCEs”,
the X partners of these gene pairs are widely expressed
dosage-sensitive regulatory genes [19, 20]. The conserva-
tion on the Y chromosome of the Y partner gene during
evolution is thought to have been driven by dosage
balance of expression and function of the X and Y
gametologs, which implies equivalent function of the two
genes. However, over time, there were varying degrees of
sequence divergence between the X and Y copies, with the
Y copies often acquiring some specific functions. Thus, a
central unresolved question is whether the X and Y part-
ner genes have similar or divergent function in different
tissues and life stages. Limited evidence to date indicates
that the function of the X and Y genes outside of the testes
is different in some cases such as Uty/Utx [105].
The RNAseq data provides a list of the X and Y genes
that are expressed in the target tissue, so it is reasonable
to prioritize any X-Y gene pairs. If any X genes are
known to show linkage to the trait, they would have a
high priority whether or not they are a member of an X-
Y gene pair. For X-Y gene pairs, the relative abundance
of X + X transcripts in XX females compared to X + Y
transcript abundance in males are not very informative
when the X and Y transcripts have diverged such that
the encoded proteins are not equivalent in activity and/
or function. Once again, the most direct approaches to
identifying the X and Y genes involved are gene targeting
and transgenesis.
Nevertheless, the possible balance of effects of X-Y pairs
could lead to an unusual scenario, in which Crosses A and
B show effects of NPX dose, or NPY dose, when in fact,
the study of FCG mice shows no direct SCE. In this case,
a likely scenario is that both members of an X-Y gene pair
have effects on the phenotype but that the effects are bal-
anced, and therefore produce no phenotypic difference in
XX vs. XY. Similarly, when gene dose is manipulated
through knockout of single copies of X-Y gene pairs, redu-
cing the dose of both X and Y partners could show a
phenotypic effect that is balanced and does not contribute
to sex differences in phenotype. The balance of X and Y
partner genes could be dynamic, however, changing under
different life conditions (stress, disease, developmental
stage, tissue type, and hormone levels) [50].
Looking for direct SCEs when there is no sex
difference
Most investigators will be drawn to the study of FCG
mice if they hypothesize a direct SCE because classical
Test FCG to find 
Sex Chromosome 
Effects and/or Gonadal 
Effects
Find XX = XY (Sex Chrom Effect)
but M = F (no Gonad Effect)
//
Find that WT XX = XY./
Test Cross A (XY* model) to 
find effects of number 
of ChrX or ChrY
Find XX = XY (Sex Chrom Effect)
but also M = F (Gonad Effect)
Test Cross C to find 
effects of number 
of ChrX or ChrY
in M and F
Test Cross A to find 
effects of 
number of ChrX in F
If there is effect of ChrX number then compare Cross B and A to detect effects of ChrX imprint
Perform RNASeq to detect X and Y genes that differ in expression in target 
tissue. Prioritize genes for knockout or transgenesis to manipulate levels of 
expression to identify genes causing direct Sex Chromosome Effect.
/
Fig. 4 Logic tree for genetic dissection of direct sex chromosome effects
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experiments of hormone removal and replacement fail
to explain a known sex difference in phenotype [69].
However, FCG mice can be informative even if a sex
difference in the phenotype is not established. In some
cases, two sex-biasing factors typical of one sex (e.g.,
female levels of estradiol and a second X chromo-
some [47]) can reduce or eliminate the effects of the
other [46, 106]. Reducing the effects of one sex-biasing
factor can therefore “unmask” the effects of another. The
“compensatory” actions of hormones and direct SCEs pro-
vides a rationale for comparing groups of FCG mice even
if there is no overt sex difference in a phenotype [106]. In
published studies, FCG mice have often been gonadecto-
mized to allow comparison of groups under conditions in
which the levels of gonadal hormones are equal, to reduce
the possibility of gonadal hormonal confounds for direct
SCEs. Direct SCEs discovered in gonadectomized (GDX)
mice are sometimes, however, reduced if the mice have
gonads or are treated with hormones after GDX [107].
Direct SCEs that are smaller in the presence of gonads or
gonadal hormones are potentially important because vari-
ous life events (aging, stress, disease) can result in reduced
levels of gonadal hormones, which can result in the emer-
gence of direct SCEs that contribute to sex differences in
physiology. The interaction of direct SCEs and hormones,
when the effect of one sex-biased variable is conditioned
by the level of the other factor, indicates that the two types
of variables (sex chromosome genes, gonadal hormones)
have convergent actions on gene pathways influencing
emergent phenotypes including the disease [45]. The
molecular nature of this interaction is unstudied to date.
Conclusions
Our attempt here has been to provide the basis for a
logical dissection of sex chromosome effects on any
phenotype in mouse. The decision tree that summarizes
this approach is shown in Fig. 4. Because the difference
in the XX and XY genomes is fundamentally a difference
in copy number of large segments of X and Y DNA, it
makes sense to start by varying the number of these
segments in combination or in isolation, to narrow down
the segments that make XX and XY mice different. A
progressive narrowing of choices can ultimately lead to
the discovery of new genetic factors that make males
and females different. The approaches suggested here
have the advantage that they mimic the natural differ-
ences between XX and XY tissues. Other methods to
search for X chromosome effects, for example, linkage
mapping for specific traits, are not equivalent and may
not detect differences caused by one vs. two X chromo-
somes. For example, study populations may not have
any variation in the X genes that contribute to direct
SCEs or variation in gene sequence may not mimic ef-
fects of X chromosome number. Similarly, studying the
effects of different strain origin of the Y chromosome
(e.g., by comparing consomic Y strains) may uncover
effects of Y chromosome variation but may not mimic
the effects of the presence vs. absence of the Y chromo-
some as it relates to sex differences in phenotype.
The approaches suggested here have already demon-
strated that both X and Y segments cause differences in
phenotype [11, 50]. Specific Y genes have been identified
that control specific aspects of spermatogenesis [73, 102,
104, 108, 109], but to date, no specific X gene has been iden-
tified that causes a sex chromosome effect. Because of the
advent of more efficient gene targeting methods, we expect
this situation to change soon. It will be interesting to dis-
cover which X imprinted or escapee genes cause differences
in physiology and disease, and how these and Y genes inter-
act with gonadal hormones to cause emergent sex differ-
ences in phenotype.
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